In this video, Peter Chin, MD, discusses the findings of the study, “Evolution of the Zenflow Spring System: A novel nitinol implant for benign prostatic hyperplasia (BPH),” presented at the 2021 American Urological Association Annual Meeting. He also discusses the investigational Zenflow Spring System’s associated advantages from the study. Chin is an associate professor at the University of Wollongong, New South Wales, Australia.
Blue light cystoscopy decreases risk of recurrence, progression in NMIBC
May 9th 2024“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.